
Christopher R. Stone
Examiner (ID: 10415, Phone: (571)270-3494 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1609, 1614, 1628, 4173 |
| Total Applications | 750 |
| Issued Applications | 250 |
| Pending Applications | 42 |
| Abandoned Applications | 457 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8294451
[patent_doc_number] => 08222240
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-17
[patent_title] => 'Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome'
[patent_app_type] => utility
[patent_app_number] => 12/328052
[patent_app_country] => US
[patent_app_date] => 2008-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12905
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12328052
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/328052 | Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome | Dec 3, 2008 | Issued |
Array
(
[id] => 5272346
[patent_doc_number] => 20090076122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'PARP Modulators and Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/326798
[patent_app_country] => US
[patent_app_date] => 2008-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12974
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076122.pdf
[firstpage_image] =>[orig_patent_app_number] => 12326798
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/326798 | PARP Modulators and Treatment of Cancer | Dec 1, 2008 | Abandoned |
Array
(
[id] => 5575948
[patent_doc_number] => 20090143310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Method of stimulating the motility of the gastrointestinal system using ipamorelin'
[patent_app_type] => utility
[patent_app_number] => 12/313956
[patent_app_country] => US
[patent_app_date] => 2008-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20888
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143310.pdf
[firstpage_image] =>[orig_patent_app_number] => 12313956
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/313956 | Method of stimulating the motility of the gastrointestinal system using ipamorelin | Nov 25, 2008 | Issued |
Array
(
[id] => 6600965
[patent_doc_number] => 20100292334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'N-ACYLHYDRAZONE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 12/744013
[patent_app_country] => US
[patent_app_date] => 2008-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6918
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292334.pdf
[firstpage_image] =>[orig_patent_app_number] => 12744013
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744013 | N-ACYLHYDRAZONE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | Nov 18, 2008 | Abandoned |
Array
(
[id] => 8920991
[patent_doc_number] => 08486926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-16
[patent_title] => 'Steroid tetrol solid state forms'
[patent_app_type] => utility
[patent_app_number] => 12/272767
[patent_app_country] => US
[patent_app_date] => 2008-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26581
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12272767
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/272767 | Steroid tetrol solid state forms | Nov 16, 2008 | Issued |
Array
(
[id] => 5452227
[patent_doc_number] => 20090068264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'Clinical Applications of Tetrahydrobiopterin, Lipoic Acid and Their Salts and Methods of Preparing Tetrahydrobiopterin Bis-Lipoate'
[patent_app_type] => utility
[patent_app_number] => 12/268244
[patent_app_country] => US
[patent_app_date] => 2008-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10110
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068264.pdf
[firstpage_image] =>[orig_patent_app_number] => 12268244
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/268244 | Clinical Applications of Tetrahydrobiopterin, Lipoic Acid and Their Salts and Methods of Preparing Tetrahydrobiopterin Bis-Lipoate | Nov 9, 2008 | Abandoned |
Array
(
[id] => 5474371
[patent_doc_number] => 20090247537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'METHODS FOR PREVENTING OR TREATING BRUXISM USING DOPAMINERGIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/264806
[patent_app_country] => US
[patent_app_date] => 2008-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6225
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247537.pdf
[firstpage_image] =>[orig_patent_app_number] => 12264806
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/264806 | METHODS FOR PREVENTING OR TREATING BRUXISM USING DOPAMINERGIC AGENTS | Nov 3, 2008 | Abandoned |
Array
(
[id] => 5447092
[patent_doc_number] => 20090048318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES'
[patent_app_type] => utility
[patent_app_number] => 12/256669
[patent_app_country] => US
[patent_app_date] => 2008-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17085
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048318.pdf
[firstpage_image] =>[orig_patent_app_number] => 12256669
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/256669 | METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES | Oct 22, 2008 | Abandoned |
Array
(
[id] => 5385177
[patent_doc_number] => 20090226422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'Chemical Inhibitors of Inhibitors of Differentiation'
[patent_app_type] => utility
[patent_app_number] => 12/253009
[patent_app_country] => US
[patent_app_date] => 2008-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27630
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226422.pdf
[firstpage_image] =>[orig_patent_app_number] => 12253009
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/253009 | Chemical inhibitors of inhibitors of differentiation | Oct 15, 2008 | Issued |
Array
(
[id] => 5285562
[patent_doc_number] => 20090099237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Methods of treating inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 12/287605
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7624
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099237.pdf
[firstpage_image] =>[orig_patent_app_number] => 12287605
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/287605 | Methods of treating inflammatory diseases | Oct 9, 2008 | Abandoned |
Array
(
[id] => 5265655
[patent_doc_number] => 20090118340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Method for inhibiting and/or preventing formation of cancer metastases and seconddary malignant cancers'
[patent_app_type] => utility
[patent_app_number] => 12/287671
[patent_app_country] => US
[patent_app_date] => 2008-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4509
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118340.pdf
[firstpage_image] =>[orig_patent_app_number] => 12287671
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/287671 | Method for inhibiting and/or preventing formation of cancer metastases and seconddary malignant cancers | Oct 8, 2008 | Abandoned |
Array
(
[id] => 5480675
[patent_doc_number] => 20090203632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CONTRACTURE'
[patent_app_type] => utility
[patent_app_number] => 12/247840
[patent_app_country] => US
[patent_app_date] => 2008-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 53805
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203632.pdf
[firstpage_image] =>[orig_patent_app_number] => 12247840
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/247840 | COMPOSITIONS AND METHODS FOR TREATING CONTRACTURE | Oct 7, 2008 | Abandoned |
Array
(
[id] => 6267652
[patent_doc_number] => 20100298393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'Modulation of Growth Hormone, DHEA, and Cortisol with Positive Modulators of AMPA Type Glutamate Receptors'
[patent_app_type] => utility
[patent_app_number] => 12/678477
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6868
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298393.pdf
[firstpage_image] =>[orig_patent_app_number] => 12678477
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/678477 | Modulation of Growth Hormone, DHEA, and Cortisol with Positive Modulators of AMPA Type Glutamate Receptors | Sep 16, 2008 | Abandoned |
Array
(
[id] => 6054598
[patent_doc_number] => 20110110958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEOPLASIA'
[patent_app_type] => utility
[patent_app_number] => 12/677705
[patent_app_country] => US
[patent_app_date] => 2008-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 25388
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20110110958.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677705
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677705 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEOPLASIA | Sep 10, 2008 | Abandoned |
Array
(
[id] => 8352068
[patent_doc_number] => 08247397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-21
[patent_title] => 'Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/208227
[patent_app_country] => US
[patent_app_date] => 2008-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 67
[patent_no_of_words] => 47191
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12208227
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/208227 | Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use | Sep 9, 2008 | Issued |
Array
(
[id] => 6350370
[patent_doc_number] => 20100249119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'HETEROCYCLIC COMPOUND AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/675663
[patent_app_country] => US
[patent_app_date] => 2008-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 167252
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249119.pdf
[firstpage_image] =>[orig_patent_app_number] => 12675663
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/675663 | Heterocyclic compound and use thereof | Aug 27, 2008 | Issued |
Array
(
[id] => 6016722
[patent_doc_number] => 20110224195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'HETEROCYCLIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES'
[patent_app_type] => utility
[patent_app_number] => 12/672100
[patent_app_country] => US
[patent_app_date] => 2008-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21556
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224195.pdf
[firstpage_image] =>[orig_patent_app_number] => 12672100
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/672100 | Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes | Aug 17, 2008 | Issued |
Array
(
[id] => 4853215
[patent_doc_number] => 20080318958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'New utilities of tricyclic compounds'
[patent_app_type] => utility
[patent_app_number] => 12/222773
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15021
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318958.pdf
[firstpage_image] =>[orig_patent_app_number] => 12222773
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/222773 | New utilities of tricyclic compounds | Aug 14, 2008 | Abandoned |
Array
(
[id] => 6048637
[patent_doc_number] => 20110207729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'BICYCLIC ACYLGUANIDINE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 12/672277
[patent_app_country] => US
[patent_app_date] => 2008-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27331
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207729.pdf
[firstpage_image] =>[orig_patent_app_number] => 12672277
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/672277 | BICYCLIC ACYLGUANIDINE DERIVATIVE | Aug 6, 2008 | Abandoned |
Array
(
[id] => 8016341
[patent_doc_number] => 08137669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-20
[patent_title] => 'Elimination of heterogeneous or mixed cell population in tumors'
[patent_app_type] => utility
[patent_app_number] => 12/186411
[patent_app_country] => US
[patent_app_date] => 2008-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 20827
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/137/08137669.pdf
[firstpage_image] =>[orig_patent_app_number] => 12186411
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/186411 | Elimination of heterogeneous or mixed cell population in tumors | Aug 4, 2008 | Issued |